These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35970241)

  • 1. Clinical and Genomic Characterization of Interval Colorectal Cancer in 3 Prospective Cohorts.
    Yang K; Cao Y; Gurjao C; Liu Y; Guo CG; Lo CH; Zong X; Drew D; Geraghty C; Prezioso E; Moore M; Williams C; Riley T; Saul M; Ogino S; Giannakis M; Bass A; Schoen RE; Chan AT
    Gastroenterology; 2022 Dec; 163(6):1522-1530.e5. PubMed ID: 35970241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mortality From Postscreening (Interval) Colorectal Cancers Is Comparable to That From Cancer in Unscreened Patients-A Randomized Sigmoidoscopy Trial.
    Jodal HC; Løberg M; Holme Ø; Adami HO; Bretthauer M; Emilsson L; Ransohoff DF; Hoff G; Kalager M
    Gastroenterology; 2018 Dec; 155(6):1787-1794.e3. PubMed ID: 30165051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal occult blood test for colorectal cancer screening: an evidence-based analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2009; 9(10):1-40. PubMed ID: 23074514
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interval Colorectal Cancer Incidence Among Subjects Undergoing Multiple Rounds of Fecal Immunochemical Testing.
    van der Vlugt M; Grobbee EJ; Bossuyt PMM; Bos A; Bongers E; Spijker W; Kuipers EJ; Lansdorp-Vogelaar I; Spaander MCW; Dekker E
    Gastroenterology; 2017 Aug; 153(2):439-447.e2. PubMed ID: 28483499
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of missed or interval colorectal cancer and patient survival: a population-based study.
    Samadder NJ; Curtin K; Tuohy TM; Pappas L; Boucher K; Provenzale D; Rowe KG; Mineau GP; Smith K; Pimentel R; Kirchhoff AC; Burt RW
    Gastroenterology; 2014 Apr; 146(4):950-60. PubMed ID: 24417818
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival of patients with symptom- and screening-detected colorectal cancer.
    Brenner H; Jansen L; Ulrich A; Chang-Claude J; Hoffmeister M
    Oncotarget; 2016 Jul; 7(28):44695-44704. PubMed ID: 27213584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characteristics and survival of interval and sporadic colorectal cancer patients: a nationwide population-based cohort study.
    Erichsen R; Baron JA; Stoffel EM; Laurberg S; Sandler RS; Sørensen HT
    Am J Gastroenterol; 2013 Aug; 108(8):1332-40. PubMed ID: 23774154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Prospective Study of Smoking and Risk of Synchronous Colorectal Cancers.
    Drew DA; Nishihara R; Lochhead P; Kuchiba A; Qian ZR; Mima K; Nosho K; Wu K; Wang M; Giovannucci E; Fuchs CS; Chan AT; Ogino S
    Am J Gastroenterol; 2017 Mar; 112(3):493-501. PubMed ID: 28117362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality indicators for screening colonoscopy and colonoscopist performance and the subsequent risk of interval colorectal cancer: a systematic review.
    Lund M; Trads M; Njor SH; Erichsen R; Andersen B
    JBI Database System Rev Implement Rep; 2019 Nov; 17(11):2265-2300. PubMed ID: 31188154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in treatment of stage I colorectal cancers: a population-based study of colorectal cancers detected within and outside of a screening program.
    Toes-Zoutendijk E; Breekveldt ECH; van der Schee L; Nagtegaal ID; Elferink MAG; Lansdorp-Vogelaar I; Moons LMG; van Leerdam ME
    Endoscopy; 2024 Jan; 56(1):5-13. PubMed ID: 37935373
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing a biological profile for interval colorectal cancers.
    Cisyk AL; Singh H; McManus KJ
    Dig Dis Sci; 2014 Oct; 59(10):2390-402. PubMed ID: 24839919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and Molecular Characteristics of Post-Colonoscopy Colorectal Cancer: A Population-based Study.
    Stoffel EM; Erichsen R; Frøslev T; Pedersen L; Vyberg M; Koeppe E; Crockett SD; Hamilton SR; Sørensen HT; Baron JA
    Gastroenterology; 2016 Nov; 151(5):870-878.e3. PubMed ID: 27443823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Equivalency of fecal immunochemical tests and colonoscopy in familial colorectal cancer screening.
    Quintero E; Carrillo M; Gimeno-García AZ; Hernández-Guerra M; Nicolás-Pérez D; Alonso-Abreu I; Díez-Fuentes ML; Abraira V
    Gastroenterology; 2014 Nov; 147(5):1021-30.e1; quiz e16-7. PubMed ID: 25127679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New and Recurrent Colorectal Cancers After Resection: a Systematic Review and Meta-analysis of Endoscopic Surveillance Studies.
    Fuccio L; Rex D; Ponchon T; Frazzoni L; Dinis-Ribeiro M; Bhandari P; Dekker E; Pellisè M; Correale L; van Hooft J; Jover R; Libanio D; Radaelli F; Alfieri S; Bazzoli F; Senore C; Regula J; Seufferlein T; Rösch T; Sharma P; Repici A; Hassan C
    Gastroenterology; 2019 Apr; 156(5):1309-1323.e3. PubMed ID: 30553914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of Screening Lower Endoscopy With Colorectal Cancer Incidence and Mortality in Adults Older Than 75 Years.
    Ma W; Wang K; Nguyen LH; Joshi A; Cao Y; Nishihara R; Wu K; Ogino S; Giovannucci EL; Song M; Chan AT
    JAMA Oncol; 2021 Jul; 7(7):985-992. PubMed ID: 34014275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical effectiveness of different surveillance strategies to prevent colorectal cancer in people with intermediate-grade colorectal adenomas: a retrospective cohort analysis, and psychological and economic evaluations.
    Atkin W; Brenner A; Martin J; Wooldrage K; Shah U; Lucas F; Greliak P; Pack K; Kralj-Hans I; Thomson A; Perera S; Wood J; Miles A; Wardle J; Kearns B; Tappenden P; Myles J; Veitch A; Duffy SW
    Health Technol Assess; 2017 Apr; 21(25):1-536. PubMed ID: 28621643
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Definition and taxonomy of interval colorectal cancers: a proposal for standardising nomenclature.
    Sanduleanu S; le Clercq CM; Dekker E; Meijer GA; Rabeneck L; Rutter MD; Valori R; Young GP; Schoen RE;
    Gut; 2015 Aug; 64(8):1257-67. PubMed ID: 25193802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Positive impact of a faecal-based screening programme on colorectal cancer mortality risk.
    Ibáñez-Sanz G; Milà N; Vidal C; Rocamora J; Moreno V; Sanz-Pamplona R; Garcia M;
    PLoS One; 2021; 16(6):e0253369. PubMed ID: 34191813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    Decker KM; Nugent Z; Lambert P; Biswanger N; Singh H
    PLoS One; 2018; 13(9):e0203321. PubMed ID: 30180176
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.